Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Genome Copying Errors02:46

Genome Copying Errors

5.0K
DNA replication is a well-evolved process that copies millions of base pairs with high fidelity during each cell division. Occasionally a wrong base or a long stretch of wrong bases may get added to the daughter strands. If the errors are left unchecked, cells might accumulate several mutations that might endanger their  survival. Therefore, the copying errors are checked and repaired at three levels.
5.0K
Mutations in Microorganisms01:18

Mutations in Microorganisms

479
Mutations are heritable changes in an organism’s genome involving alterations in the base sequence of DNA or RNA. These changes can influence cellular processes and phenotypic traits, potentially transforming the unaltered wild type into a mutant form. Such changes, termed forward mutations, are pivotal in shaping the genetic diversity of organisms.RNA viruses exhibit the highest mutation rates due to the absence of robust proofreading mechanisms during genome replication. In contrast,...
479
Mismatch Repair01:20

Mismatch Repair

6.2K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.2K
Mismatch Repair01:36

Mismatch Repair

43.5K
Overview
43.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Mutations01:39

Mutations

94.3K
Overview
94.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Efficacy, safety, and biomarker analysis of datopotamab deruxtecan in advanced non-small cell lung cancer: ICARUS-LUNG01 phase 2 study.

Cancer cell·2026
Same author

Psoriatic arthritis monocyte DNA methylomes bridge joint and skin inflammatory pathways across rheumatoid arthritis and psoriasis.

Annals of the rheumatic diseases·2026
Same author

fRagmentomics: an R package for integrating cell-free DNA fragment features with mutational status to support liquid biopsy interpretation.

Bioinformatics (Oxford, England)·2026
Same author

Utilisation of spatial methodologies for the investigation of the tumour microenvironment.

Methods in cell biology·2026
Same author

Author Correction: Microglial colonization of the developing mouse brain is controlled by both microglial and neural CSF-1.

The EMBO journal·2026

相关实验视频

Updated: Jan 9, 2026

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

4.7K

当血液突变变为有益时.

Carlos de la Calle-Fabregat1, Elsa Bernard2, Florent Ginhoux1

  • 1Paris-Saclay University, Gustave Roussy, INSERM U1015, Villejuif, France.

Cancer cell
|December 5, 2025
PubMed
概括

癌症患者的TET2突变克隆性血液形成 (CH) 可以提高免疫治疗的有效性. 这通过增强巨抗原呈现和T细胞激活来发生,从而导致更好的治疗结果.

科学领域:

  • 免疫学 免疫学 免疫学
  • 在瘤学瘤学.
  • 遗传学 是一个遗传学.

背景情况:

  • 克隆性造血 (CH),其特点是具有体质突变的扩大造血克隆,在固体瘤患者中很普遍.
  • CH与癌症的不良临床结果有关.
  • 对于抗癌疗法的反应中CH的作用仍然不完全理解.

研究的目的:

  • 调查TET2突变克隆性血液形成对癌症免疫疗法的疗效的影响.
  • 阐明CH影响抗瘤免疫反应的机制.

主要方法:

  • 对患有固体瘤和CH的患者的分析.
  • 免疫组织化学染色和流动细胞测量以评估免疫细胞群和功能.
  • 在体内和体外测试以评估抗原呈现和T细胞激活.

主要成果:

  • 发现TET2突变CH可以增强巨细胞抗原呈现.
  • 这种增强导致了瘤微环境中CD8+T细胞激活的增加.
  • 改善的抗原呈现和T细胞激活与免疫治疗的更好的治疗疗效相关.

结论:

  • 在癌症患者中,TET2-突变的克隆性血液形成积极调节免疫反应对免疫疗法的免疫反应.

更多相关视频

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
11:06

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Published on: February 24, 2014

13.4K
Characterizing Mutational Load and Clonal Composition of Human Blood
07:58

Characterizing Mutational Load and Clonal Composition of Human Blood

Published on: July 11, 2019

7.8K

相关实验视频

Last Updated: Jan 9, 2026

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

4.7K
Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
11:06

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Published on: February 24, 2014

13.4K
Characterizing Mutational Load and Clonal Composition of Human Blood
07:58

Characterizing Mutational Load and Clonal Composition of Human Blood

Published on: July 11, 2019

7.8K
  • CH可以增强巨细胞的功能,改善抗原呈现和T细胞反应.
  • 向或理解CH可能为改善癌症免疫治疗结果提供新的策略.